EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category  |
Confidence Level |
|---|
    3.1.1.23 | Alzheimer Disease |
21459826 |
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. |
causal interaction
unassigned |
1
0 |
| 3.1.1.23 | Alzheimer Disease |
32483456 |
Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
| 3.1.1.23 | Carcinoma, Hepatocellular |
27767105 |
Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
4
4
0 |
| 3.1.1.23 | Carcinoma, Hepatocellular |
27884159 |
Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-?B-mediated epithelial-mesenchymal transition. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
3
1
0 |
| 3.1.1.23 | Colorectal Neoplasms |
21543155 |
Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
3
0 |
| 3.1.1.23 | Colorectal Neoplasms |
22349814 |
Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
4
1 |
| 3.1.1.23 | Colorectal Neoplasms |
34431463 |
Targeting triglyceride metabolism for colorectal cancer prevention and therapy. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
1
2
1
0 |
| 3.1.1.23 | Glaucoma |
30446439 |
Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.1.1.23 | Neoplasms |
20079333 |
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. |
causal interaction
ongoing research
unassigned |
2
3
0 |
| 3.1.1.23 | Neoplasms |
30696302 |
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
